DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Dicerna Pharmaceuticals, Inc. (DRNA)
« Back to company indexDRNA Chatter Timeline
Stock Ticker for DRNA
Most Active Tweeters for DRNA
| User | Tweets |
|---|---|
| @gcassidy718 | 6 |
| @TheMarketsDaily | 4 |
| @macondailynews | 3 |
| @BlueBioNow | 3 |
| @StockTexts | 2 |
Recent Tweets for DRNA
 |
@InsiderAlertsIA $DRNA: New Insider Filing on EVP & Chief Operating Officer JAMES B WEISSMAN: https://t.co/mSZ36cQLlY October 21st 2019, 8:10am |
 |
@dispatchtribune Dicerna Pharmaceuticals $DRNA Raised to “Buy” at BidaskClub https://t.co/hprpKUjGbz October 21st 2019, 7:10am |
 |
@gcassidy718 $DRNA holding until $18.03 dollars a share https://t.co/og81erSpQm October 20th 2019, 1:10pm |
 |
@TheMarketsDaily Dicerna Pharmaceuticals $DRNA Rating Increased to Buy at BidaskClub https://t.co/seVTTMC2r9 October 20th 2019, 9:10am |
 |
@registrarjourn Dicerna Pharmaceuticals $DRNA Raised to “Buy” at BidaskClub https://t.co/MqXneaAyTh October 20th 2019, 9:10am |
 |
@EnterpriseLeade Dicerna Pharmaceuticals $DRNA Raised to “Buy” at BidaskClub https://t.co/EDFXNWtxug October 20th 2019, 9:10am |
 |
@the_chart_life $DRNA Dicerna Pharma ..."Focuses on the discovery and development of ribonucleic acid interference (RNAi)-based pha… https://t.co/rjniQjm75d October 20th 2019, 12:10am |
 |
@TickerReport Dicerna Pharmaceuticals $DRNA Rating Increased to Buy at BidaskClub https://t.co/U1NRvp4d1o October 19th 2019, 4:10pm |
 |
@BlueBioNow $DRNA blockbuster 3.73 % change recently https://t.co/6L4jysCGvR October 19th 2019, 1:10pm |
 |
@dailypoliticaln Zacks Investment Research Downgrades Dicerna Pharmaceuticals $DRNA to Sell https://t.co/xtWLkkp2t4 October 19th 2019, 11:10am |
 |
@ZolmaxNews Zacks Investment Research Downgrades Dicerna Pharmaceuticals $DRNA to Sell https://t.co/PlTkwhtYnd October 19th 2019, 11:10am |
 |
@ThisLincolnian Dicerna Pharmaceuticals $DRNA Trading 5.4% Higher https://t.co/jFkwHqnoyt October 19th 2019, 10:10am |
 |
@StockTexts $DRNA Dicerna Pharmaceuticals, Inc. SEC Filing: Form 4 https://t.co/3dUWZrSNAI October 19th 2019, 9:10am |
 |
@1MinuteStock Wondering about #sentiment indicator for $DRNA? The Short Ratio is 11.21% https://t.co/cK96TdziHl October 18th 2019, 10:10pm |
|
@StockTexts $DRNA Dicerna Pharmaceuticals, Inc. SEC Filing: Form 4 https://t.co/3dUWZsaoZi October 18th 2019, 7:10pm |
 |
@confcalltran Dicerna Pharmaceuticals's EVP %26 Chief Operating Officer just picked up 4,904 shares https://t.co/30NOk4oTva $DRNA October 18th 2019, 7:10pm |
 |
@Jon12508683 $drna, nice weekly candle. per last cc, "We look forward to announcing proof-of-concept data for DCR-HBVS in the fi… https://t.co/X4VVGSfutM October 18th 2019, 5:10pm |
 |
@1111DLH61 $DRNA getting very extended here October 18th 2019, 3:10pm |
 |
@TranscriptDaily BidaskClub Upgrades Dicerna Pharmaceuticals $DRNA to Buy https://t.co/SP71KDGRrD October 18th 2019, 10:10am |
 |
@stocknewstimes BidaskClub Upgrades Dicerna Pharmaceuticals $DRNA to Buy https://t.co/dofAUqA4hu October 18th 2019, 10:10am |
|
@TheMarketsDaily Dicerna Pharmaceuticals $DRNA Trading 5.4% Higher https://t.co/t7w4ucROZ9 October 17th 2019, 8:10pm |
 |
@macondailynews Dicerna Pharmaceuticals $DRNA Trading 5.4% Higher https://t.co/f4apSXSVJY October 17th 2019, 8:10pm |
|
@BlueBioNow $DRNA what a Company 3.27 % change recently https://t.co/6L4jysCGvR October 17th 2019, 3:10pm |
|
@dispatchtribune Dicerna Pharmaceuticals $DRNA Stock Rating Lowered by Zacks Investment Research https://t.co/1K7sfNvhRI October 17th 2019, 4:10am |
|
@ThisLincolnian Dicerna Pharmaceuticals $DRNA Stock Rating Lowered by Zacks Investment Research https://t.co/m1yEhscYTa October 17th 2019, 4:10am |
|
@BlueBioNow $DRNA might be worth taking a position when this bottoms 2.76 % change recently https://t.co/6L4jysCGvR October 16th 2019, 12:10am |
 |
@OlympiaReport Zacks Investment Research Downgrades Dicerna Pharmaceuticals $DRNA to Sell https://t.co/zjXBbQ54bq October 15th 2019, 11:10pm |
 |
@WeekHerald Zacks Investment Research Downgrades Dicerna Pharmaceuticals $DRNA to Sell https://t.co/zx2RqhPAMe October 15th 2019, 11:10pm |
|
@gcassidy718 $DRNA here we go!! 2.29 % change recently https://t.co/og81erSpQm October 14th 2019, 3:10pm |
|
@gcassidy718 $DRNA holding until $16.34 dollars a share https://t.co/og81erSpQm October 13th 2019, 2:10pm |
|
@TheMarketsDaily Dicerna Pharmaceuticals Inc $DRNA Expected to Announce Quarterly Sales of $11.70 Million https://t.co/YmIZLxenLC October 12th 2019, 9:10pm |
 |
@dakotafinancial $11.70 Million in Sales Expected for Dicerna Pharmaceuticals Inc $DRNA This Quarter https://t.co/n6LNQYTDw4 October 12th 2019, 9:10pm |
|
@gcassidy718 $DRNA holding until $16.34 dollars a share https://t.co/og81erAOYO October 12th 2019, 3:10pm |
|
@macondailynews Zacks: Brokerages Expect Dicerna Pharmaceuticals Inc $DRNA to Announce -$0.29 Earnings Per Share https://t.co/qVe2k79EYz October 11th 2019, 3:10pm |
|
@TheMarketsDaily Zacks: Analysts Expect Dicerna Pharmaceuticals Inc $DRNA Will Announce Earnings of -$0.29 Per Share https://t.co/4VahWGn2Y9 October 11th 2019, 3:10pm |
|
@gcassidy718 $DRNA holding until $15.75 dollars a share https://t.co/og81erSpQm October 9th 2019, 1:10pm |
|
@dakotafinancial -$0.29 Earnings Per Share Expected for Dicerna Pharmaceuticals Inc $DRNA This Quarter https://t.co/ztE0RKDiZF October 9th 2019, 9:10am |
|
@macondailynews Dicerna Pharmaceuticals Inc $DRNA Expected to Post Quarterly Sales of $11.70 Million https://t.co/HjjZxmvJzi October 9th 2019, 9:10am |
|
@gcassidy718 $DRNA might be worth taking a position when this bottoms -3.32 % change recently https://t.co/og81erSpQm October 8th 2019, 6:10pm |
 |
@DataTrials $DRNA Phase 2 A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyp… https://t.co/9SObYcvEMK October 8th 2019, 7:10am |
|
@WeekHerald Analyzing Dicerna Pharmaceuticals $DRNA & Aimmune Therapeutics $AIMT https://t.co/oovNYS3BI9 October 8th 2019, 4:10am |
 |
@RNAiAnalyst Comparison of $ABUS and $DRNA HBV RNAi agents in AAV mouse model: https://t.co/QZPrpNECiV October 7th 2019, 4:10pm |
 |
@mikegoodma $DRNA at Chardan conf. FDA said redux urinary oxalate alone is an approvable endpoint for PH1. Fambrough confident… https://t.co/wvtZLEEa4P October 7th 2019, 2:10pm |
 |
@AmericanBanking Brokerages Expect Dicerna Pharmaceuticals Inc $DRNA Will Post Quarterly Sales of $11.70 Million https://t.co/sVA7i7yn53 #stocks October 6th 2019, 12:10pm |
|
@dailypoliticaln Brokerages Set Dicerna Pharmaceuticals Inc $DRNA PT at $23.00 https://t.co/jEasfU63hY October 5th 2019, 10:10am |
|
@macondailynews Dicerna Pharmaceuticals Inc $DRNA Receives Consensus Rating of “Buy” from Analysts https://t.co/vkzHNeyxg0 October 5th 2019, 10:10am |
|
@battagliame30 @_Superbrat_ @JPZaragoza1 Is $VIR deciding not to go after Protein-X(HBX) like $DRNA. Guess all these questions hav… https://t.co/PTdLtgESHC October 5th 2019, 12:10am |
 |
@SeekingAlpha $DRNA - Dicerna Pharmaceuticals (DRNA) Presents At Cantor Healthcare Conference - Slideshow. Read more and get upda… https://t.co/3Qiw7zmI38 October 4th 2019, 2:10pm |
|
@mikegoodma $DRNA's only remaining proprietary undisclosed asset is for a large-population disease. It entered the pipeline lat… https://t.co/sxoURZWUpL October 4th 2019, 2:10pm |
|
@AmericanBanking -$0.29 Earnings Per Share Expected for Dicerna Pharmaceuticals Inc $DRNA This Quarter https://t.co/6sW5uMGYGF #stocks October 4th 2019, 1:10am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.